Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
2.
EBioMedicine ; 29: 146-154, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29519670

ABSTRACT

BACKGROUND: T-cell responses against highly conserved influenza antigens have been previously associated with protection. However, these immune responses are poorly maintained following recovery from influenza infection and are not boosted by inactivated influenza vaccines. We have previously demonstrated the safety and immunogenicity of two viral vectored vaccines, modified vaccinia virus Ankara (MVA) and the chimpanzee adenovirus ChAdOx1 expressing conserved influenza virus antigens, nucleoprotein (NP) and matrix protein-1 (M1). We now report on the safety and long-term immunogenicity of multiple combination regimes of these vaccines in young and older adults. METHODS: We conducted a Phase I open-label, randomized, multi-center study in 49 subjects aged 18-46years and 24 subjects aged 50years or over. Following vaccination, adverse events were recorded and the kinetics of the T cell response determined at multiple time points for up to 18months. FINDINGS: Both vaccines were well tolerated. A two dose heterologous vaccination regimen significantly increased the magnitude of pre-existing T-cell responses to NP and M1 after both doses in young and older adults. The fold-increase and peak immune responses after a single MVA-NP+M1 vaccination was significantly higher compared to ChAdOx1 NP+M1. In a mixed regression model, T-cell responses over 18months were significantly higher following the two dose vaccination regimen of MVA/ChAdOx1 NP+M1. INTERPRETATION: A two dose heterologous vaccination regimen of MVA/ChAdOx1 NP+M1 was safe and immunogenic in young and older adults, offering a promising vaccination strategy for inducing long-term broadly cross-reactive protection against influenza A. FUNDING SOURCE: Medical Research Council UK, NIHR BMRC Oxford.

3.
Sci Rep ; 5: 11193, 2015 Jun 11.
Article in English | MEDLINE | ID: mdl-26063320

ABSTRACT

Malaria transmission-blocking vaccines (TBVs) target the development of Plasmodium parasites within the mosquito, with the aim of preventing malaria transmission from one infected individual to another. Different vaccine platforms, mainly protein-in-adjuvant formulations delivering the leading candidate antigens, have been developed independently and have reported varied transmission-blocking activities (TBA). Here, recombinant chimpanzee adenovirus 63, ChAd63, and modified vaccinia virus Ankara, MVA, expressing AgAPN1, Pfs230-C, Pfs25, and Pfs48/45 were generated. Antibody responses primed individually against all antigens by ChAd63 immunization in BALB/c mice were boosted by the administration of MVA expressing the same antigen. These antibodies exhibited a hierarchy of inhibitory activity against the NF54 laboratory strain of P. falciparum in Anopheles stephensi mosquitoes using the standard membrane feeding assay (SMFA), with anti-Pfs230-C and anti-Pfs25 antibodies giving complete blockade. The observed rank order of inhibition was replicated against P. falciparum African field isolates in A. gambiae in direct membrane feeding assays (DMFA). TBA achieved was IgG concentration dependent. This study provides the first head-to-head comparative analysis of leading antigens using two different parasite sources in two different vector species, and can be used to guide selection of TBVs for future clinical development using the viral-vectored delivery platform.


Subject(s)
Malaria Vaccines/immunology , Malaria, Falciparum/prevention & control , Malaria, Falciparum/transmission , Plasmodium falciparum/immunology , Animals , Anopheles/genetics , Anopheles/immunology , Antibodies, Protozoan/immunology , Antigens, Protozoan/genetics , Antigens, Protozoan/immunology , Culicidae/genetics , Culicidae/immunology , Disease Models, Animal , Genetic Vectors/genetics , Humans , Immunization , Immunoglobulin G , Malaria Vaccines/genetics , Mice , Recombinant Fusion Proteins
5.
Int Endod J ; 47(8): 756-68, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24246147

ABSTRACT

AIM: To establish a nutrient-stressed multispecies model biofilm and investigate the dynamics of biofilm killing and disruption by 1% trypsin and 1% proteinase K with or without ultrasonic activation. METHODOLOGY: Nutrient-stressed biofilms (Propionibacterium acnes, Staphylococcus epidermidis, Actinomyces radicidentis, Streptococcus mitis and Enterococcus faecalis OMGS 3202) were grown on hydroxyapatite discs and in prepared root canals of single-rooted teeth in modified fluid universal medium. The treatment groups included trypsin, proteinase K, 0.2% chlorhexidine gluconate and 1% sodium hypochlorite (NaOCl) (with and without ultrasonics). NaOCl and chlorhexidine were the positive controls and untreated group, and sterile saline was the negative control. The biofilms were investigated using confocal laser scanning microscopy (CLSM) with live/dead staining and quantitative microbial culture. RESULTS: Nutrient stress in the multispecies biofilm was apparent as the medium pH became alkaline, glucose was absent, and serum proteins were degraded in the supernatant. The CLSM showed the percentage reduction in viable bacteria at the biofilm surface level due to nutrient starvation. On the disc model, trypsin and proteinase K were effective in killing bacteria; their aerobic viable counts were significantly lower (P < 0.01) than the negative control and chlorhexidine. NaOCl was the most effective agent (P < 0.001). In the tooth model, when compared to saline, trypsin with ultrasonics caused significant killing both aerobically and anaerobically (P < 0.05). Chlorhexidine (1.46 ± 0.42), trypsin (3.56 ± 1.18) and proteinase K (4.2 ± 1.01) with ultrasonics were significantly effective (P < 0.05) in reducing the substratum coverage as compared to saline with ultrasonics (12% ± 4.9). CONCLUSION: Trypsin with ultrasonic activation has a biofilm killing and disrupting potential.


Subject(s)
Biofilms , Endodontics , Therapeutic Irrigation , Humans , Tooth Root/microbiology
6.
J Virol ; 86(10): 5452-66, 2012 May.
Article in English | MEDLINE | ID: mdl-22419811

ABSTRACT

Dendritic cells (DC) are potent antigen-presenting cells and central to the induction of immune responses following infection or vaccination. The collection of DC migrating from peripheral tissues by cannulation of the afferent lymphatic vessels provides DC which can be used directly ex vivo without extensive in vitro manipulations. We have previously used bovine migrating DC to show that recombinant human adenovirus 5 vectors efficiently transduce afferent lymph migrating DEC-205(+) CD11c(+) CD8(-) DC (ALDC). We have also shown that recombinant modified vaccinia virus Ankara (MVA) infects ALDC in vitro, causing downregulation of costimulatory molecules, apoptosis, and cell death. We now show that in the bovine system, modified vaccinia virus Ankara-induced apoptosis in DC draining from the skin occurs soon after virus binding via the caspase 8 pathway and is not associated with viral gene expression. We also show that after virus entry, the caspase 9 pathway cascade is initiated. The magnitude of T cell responses to mycobacterial antigen 85A (Ag85A) expressed by recombinant MVA-infected ALDC is increased by blocking caspase-induced apoptosis. Apoptotic bodies generated by recombinant MVA (rMVA)-Ag85A-infected ALDC and containing Ag85A were phagocytosed by noninfected migrating ALDC expressing SIRPα via actin-dependent phagocytosis, and these ALDC in turn presented antigen. However, the addition of fresh ALDC to MVA-infected cultures did not improve on the magnitude of the T cell responses; in contrast, these noninfected DC showed downregulation of major histocompatibility complex class II (MHC-II), CD40, CD80, and CD86. We also observed that MVA-infected ALDC promoted migration of DEC-205(+) SIRPα(+) CD21(+) DC as well as CD4(+) and CD8(+) T cells independently of caspase activation. These in vitro studies show that induction of apoptosis in DC by MVA vectors is detrimental to the subsequent induction of T cell responses.


Subject(s)
Antigen Presentation , Apoptosis , Caspases/metabolism , Dendritic Cells/cytology , Tuberculosis/immunology , Vaccinia virus/immunology , Viral Vaccines/immunology , Animals , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Caspases/genetics , Caspases/immunology , Cattle , Dendritic Cells/immunology , Dendritic Cells/metabolism , Down-Regulation , Genetic Vectors/genetics , Genetic Vectors/immunology , Humans , Mycobacterium bovis/genetics , Mycobacterium bovis/immunology , Signal Transduction , Tuberculosis/enzymology , Tuberculosis/physiopathology , Tuberculosis/virology , Vaccinia virus/genetics , Vaccinia virus/physiology , Viral Vaccines/genetics
7.
Vaccine ; 30(13): 2357-67, 2012 Mar 16.
Article in English | MEDLINE | ID: mdl-22281103

ABSTRACT

Understanding how pathogens or vaccine antigens are targeted to dendritic cell (DC) subsets is important for disease pathogenesis studies and vaccine design. We characterised the sub-populations of migrating bovine DC with functional and phenotypic diversity present in pseudoafferent lymph draining the skin. These skin draining DC exist as a series of maturation dependent subsets with differential capacities for antigen uptake and cytokine expression, and include both Langerhans' cells (LC) and dermal derived cells. Furthermore, Mycobacterium bovis Bacille Calmette Guerin, a vaccine which is administered by the intradermal route, was only taken up by a small number of the migrating DC, which were SIRPα(+) and expressed the mannose receptor and CD1b. This was evident following in vitro infection and also in vivo following inoculation of green fluorescent BCG over the lymphatic cannulation site. Only the SIRPα(+) DC were able to present antigen to T cells isolated from BCG vaccinated calves. Furthermore, presentation of BCG antigens by DC to T lymphocytes was ineffective compared to mycobacterial proteins. However, mycobacterial antigen 85 was delivered more effectively to DC via an adenoviral vector and the magnitude of the subsequent antigen-specific T cell response was significantly increased. This study further extends our understanding of the biology of migrating DC, identifies potential explanations for the modest success of BCG vaccination and demonstrates that targeted delivery of antigens via adenoviruses to DC can improve antigen presentation.


Subject(s)
Antigen-Presenting Cells/immunology , BCG Vaccine/immunology , Cell Movement , Dendritic Cells/immunology , Lymph Nodes/immunology , Mycobacterium bovis/immunology , Adenoviridae/genetics , Adenoviridae/immunology , Animals , Antigen Presentation/immunology , Antigen-Presenting Cells/cytology , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Cattle , Cytokines/biosynthesis , Dendritic Cells/cytology , Dermis/immunology , Langerhans Cells/immunology , Lectins, C-Type/metabolism , Lymphocyte Activation , Mannose Receptor , Mannose-Binding Lectins/metabolism , Phenotype , Receptors, Cell Surface/metabolism , Receptors, Immunologic/metabolism , T-Lymphocytes/immunology
8.
Mol Oral Microbiol ; 26(5): 291-302, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21896156

ABSTRACT

A collection of Streptococcus sanguinis strains from patients with endocarditis (n = 21) and from the oral cavity (n = 34) was subjected to a multi-locus sequence typing analysis using seven housekeeping genes, carbamoyl-phosphate synthetase (carB), Co/Zn/Cd efflux system component (czcD), d-alanyl-d-alanine ligase (ddl), DNA polymerase III (dnaX), glucose-6-phosphate dehydrogenase (gdh), DNA-directed RNA polymerase, beta subunit (rpoB) and superoxide dismutase (sodA). The scheme was expanded by the inclusion of two the putative virulence genes, bacitracin-resistance protein (bacA) and saliva-binding protein (ssaB), to increase strain discrimination. Extensive intra-species recombination was apparent in all genes but inter-species recombination was also apparent with strains apparently harbouring gdh and ddl from unidentified sources and one isolate harboured a sodA allele apparently derived from Streptococcus oralis. The recombination/mutation ratio for the concatenated housekeeping gene sequences was 1.67 (95% confidence limits 1.25-2.72) and for the two virulence genes the r/m ratio was 3.99 (95% confidence limits 1.61-8.72); recombination was the major driver for genetic variation. All isolates were distinct and the endocarditis strains did not form distinct sub-clusters when the data were analysed using ClonalFrame. These data support the widely held opinion that infecting S. sanguinis strains are opportunistic human pathogens.


Subject(s)
Dental Plaque/microbiology , Endocarditis, Bacterial/microbiology , Genes, Bacterial/genetics , Streptococcus sanguis/genetics , Clone Cells , Endocarditis, Bacterial/blood , Genes, Essential/genetics , Genetic Variation , Humans , Multilocus Sequence Typing , Opportunistic Infections/microbiology , Phylogeny , Recombination, Genetic
9.
J Virol ; 85(18): 9385-94, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21752909

ABSTRACT

Targeting dendritic cells (DC) is key to driving effective immune responses. Lymphatic cannulation provides access to the heterogeneous populations of DC draining peripheral sites in rodents and ruminants. Afferent lymph DEC-205(+) CD11c(+) SIRPα(+) DC were preferentially infected ex vivo with three vaccine viral vectors: recombinant human replication-defective human adenovirus 5 (rhuAdV5), recombinant modified vaccinia virus Ankara (rMVA), and recombinant fowlpox virus (rFPV), all expressing green fluorescent protein (GFP). The rhuAdV5-infected cells remained viable, and peak GFP expression was observed 16 to 24 h posttransduction. Increasing the incubation period of DC with rhuAdV5 enhanced GFP expression. In contrast, DC infected with rMVA-GFP or rFPV-GFP became rapidly apoptotic and GFP expression peaked at 6 h postinfection. Delivery of foot-and-mouth disease virus (FMDV) A(22) antigen to DC by rhuAdV5-FMDV-A(22) ex vivo resulted in significantly greater CD4(+) T cell proliferation than did delivery by rFPV-FMDV-A(22). Delivery of rhuAdV5-GFP in oil adjuvant in vivo, to enhance DC-vector contact, resulted in increased GFP expression in migrating DC compared to that with vector alone. Similarly, CD4(+) T cell responses were significantly enhanced when using rhuAdV5-FMDV-A(22) in adjuvant. Therefore, the interaction between viral vectors and afferent lymph DC ex vivo can predict the outcome of in vivo immunization and provide a means of rapidly assessing the effects of vector modification.


Subject(s)
Adenoviruses, Human/immunology , Dendritic Cells/immunology , Dendritic Cells/virology , Fowlpox virus/immunology , Vaccinia virus/immunology , Viral Vaccines/immunology , Adenoviruses, Human/genetics , Adenoviruses, Human/pathogenicity , Animals , Antigens, Viral/genetics , Antigens, Viral/immunology , CD4-Positive T-Lymphocytes/immunology , Cattle , Cell Proliferation , Cell Survival , Foot-and-Mouth Disease Virus/genetics , Foot-and-Mouth Disease Virus/immunology , Fowlpox virus/pathogenicity , Lymph Nodes/cytology , Lymph Nodes/immunology , Vaccination/methods , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Vaccinia virus/pathogenicity , Viral Vaccines/administration & dosage , Viral Vaccines/genetics
10.
J Infect Dis ; 203(9): 1337-40, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21459819

ABSTRACT

Naturally acquired immunity to Plasmodium falciparum's asexual blood stage reduces parasite multiplication at microscopically detectable densities. The effect of natural immunity on initial prepatent parasite multiplication during the period following a new infection has been uncertain, contributing to doubt regarding the utility of experimental challenge models for blood-stage vaccine trials. Here we present data revealing that parasite multiplication rates during the initial prepatent period in semi-immune Gambian adults are substantially lower than in malaria-naive participants. This supports the view that a blood-stage vaccine capable of emulating the disease-reducing effect of natural immunity could achieve a detectable effect during the prepatent period.


Subject(s)
Adaptive Immunity , Malaria, Falciparum/immunology , Parasitology/methods , Plasmodium falciparum/growth & development , Plasmodium falciparum/immunology , Adult , Gambia , Humans , Microscopy/methods
11.
Infect Immun ; 78(11): 4601-12, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20713623

ABSTRACT

Although merozoite surface protein 1 (MSP-1) is a leading candidate vaccine antigen for blood-stage malaria, its efficacy in clinical trials has been limited in part by antigenic polymorphism and potentially by the inability of protein-in-adjuvant vaccines to induce strong cellular immunity. Here we report the design of novel vectored Plasmodium falciparum vaccines capable of overcoming such limitations. We optimized an antigenic insert comprising the four conserved blocks of MSP-1 fused to tandemly arranged sequences that represent both allelic forms of the dimorphic 42-kDa C-terminal region. Inserts were expressed by adenoviral and poxviral vectors and employed in heterologous prime-boost regimens. Simian adenoviral vectors were used in an effort to circumvent preexisting immunity to human adenoviruses. In preclinical studies these vaccines induced potent cellular immune responses and high-titer antibodies directed against MSP-1. The antibodies induced were found to have growth-inhibitory activity against dimorphic allelic families of P. falciparum. These vectored vaccines should allow assessment in humans of the safety and efficacy of inducing strong cellular as well as cross-strain humoral immunity to P. falciparum MSP-1.


Subject(s)
DNA Viruses/genetics , Erythrocytes/parasitology , Genetic Vectors , Malaria Vaccines , Malaria, Falciparum/prevention & control , Merozoite Surface Protein 1/metabolism , Adenoviruses, Human/genetics , Adenoviruses, Simian/genetics , Animals , Antibodies, Protozoan/blood , Chick Embryo , Drug Design , Female , Humans , Immunization , Immunization, Secondary , Malaria Vaccines/administration & dosage , Malaria Vaccines/genetics , Malaria Vaccines/immunology , Malaria, Falciparum/immunology , Malaria, Falciparum/parasitology , Merozoite Surface Protein 1/genetics , Merozoite Surface Protein 1/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Plasmodium falciparum/immunology , T-Lymphocytes/immunology , Vaccinia virus/genetics
12.
Nephron Clin Pract ; 116(4): c337-46, 2010.
Article in English | MEDLINE | ID: mdl-20664290

ABSTRACT

OBJECTIVE: The prevalence of primary glomerulonephritis in Singapore is compared with that of 28 other countries to review changing trends in the evolution of primary glomerulonephritis in Asia and other countries. METHOD: 2,586 renal biopsies in Singapore over the past 3 decades were reviewed and compared with data from 28 other countries. RESULTS: In the 1st decade most Asian countries have mesangial proliferative glomerulonephritis as the most common form of primary glomerulonephritis, and in the 3rd decade there has been a dramatic increase in focal and segmental glomerulosclerosis reflecting aging and obesity in keeping with more developed countries. IgA nephritis remains the commonest glomerulonephritis in many countries. Membranous glomerulonephritis continues to be more prevalent in Western countries while mesangial proliferative glomerulonephritis remains prevalent in many Asian countries. CONCLUSION: Apart from geographical and genetic influences, socioeconomic factors may play a role in the evolution of the biopsy pattern in some countries. Worldwide, the prevalence of focal segmental glomerulosclerosis continues to increase. In third world countries some of the commoner forms of glomerulonephritis are related to infections, in contrast to developed countries where the antigenic exposure may be related to diet, allergens and other industrial agents.


Subject(s)
Global Health , Glomerulonephritis/diagnosis , Glomerulonephritis/epidemiology , Animals , Glomerulonephritis/etiology , Humans , Internationality , Prevalence , Risk Factors , Singapore/epidemiology
13.
Mol Oral Microbiol ; 25(3): 190-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20536746

ABSTRACT

The microbiota of the denture plaque biofilm colonizing the fitting surface of dentures in edentulous subjects with healthy palates (n = 20) and in edentulous subjects with denture stomatitis (n = 20) was studied. The numbers of bacteria colonizing the dentures of healthy subjects was significantly less than the numbers colonizing the dentures of stomatitis subjects. The proportions and frequency of isolation of mutans streptococci, lactobacilli, bifidobacteria and yeasts were significantly (P < 0.05) greater in the subjects with denture stomatitis. The proportions of these organisms in the denture plaque biofilm of the subjects with denture stomatitis were similar to those found in carious lesions, indicating that the site is a low pH environment. The predominant bifidobacterial species in the mouths of dentate subjects is Bifidobacterium dentium but in the edentulous subjects wearing dentures B. dentium was isolated from only one of the 20 subjects with denture stomatitis and from none of the 20 subjects with healthy palates. Instead, Bifidobacterium breve, Bifidobacterium scardovii and Bifidobacterium longum subsp. longum were isolated. Only a single non-oral bifidobacterial species was isolated from each individual and repetitive extragenic palindromic- and BOX-polymerase chain reaction typing methods indicated that the same genotypes were shared between subjects. Using deferred antagonism spot plate assays, interspecies inhibition was demonstrated between oral isolates of B. dentium, B. breve, B. scardovii and B. longum subsp. longum. Here we have shown that bifidobacteria and caries-associated microbiota are present in denture plaque at levels similar to those of carious lesions and B. dentium cannot be maintained in an edentulous mouth.


Subject(s)
Bifidobacterium/physiology , Dental Caries/microbiology , Dental Plaque/microbiology , Denture, Complete, Upper/microbiology , Stomatitis, Denture/microbiology , Aged , Antibiosis , Bifidobacterium/isolation & purification , Biofilms , Case-Control Studies , Chi-Square Distribution , Colony Count, Microbial , DNA, Bacterial/analysis , Female , Humans , Hydrogen-Ion Concentration , Male , Middle Aged , Statistics, Nonparametric
14.
J Dent Res ; 89(9): 970-4, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20505050

ABSTRACT

Bifidobacteria are aciduric bacteria that might play a role in the caries process. To test the hypothesis that Bifidobacteria behave as caries-associated organisms, as predicted by the ecological plaque hypothesis, we determined salivary levels of Bifidobacteria and caries-associated organisms for 156 older adults. Salivary levels of Bifidobacteria, mutans streptococci, lactobacilli, and yeasts were correlated with each other (p < 0.001), negatively correlated with salivary flow rate (p < 0.001), and positively correlated with plaque index (p < 0.05). Salivary Bifidobacteria levels were positively associated with the number of filled (p < 0.001) and decayed (p = 0.036) tooth surfaces and negatively associated with number of teeth (p < 0.001) and salivary flow rate (p = 0.049). In regression analyses, caries experience was significantly associated with only salivary Bifidobacteria (p < 0.001) and yeast (p < 0.001) levels and the individual's age (p = 0.021). Bifidobacteria should be regarded as caries-associated organisms whose role in the caries process and as markers of caries risk requires further investigation.


Subject(s)
Bifidobacterium/pathogenicity , Dental Caries/microbiology , Saliva/microbiology , Aged , Aged, 80 and over , Bifidobacterium/isolation & purification , Colony Count, Microbial , Culture Media/chemistry , DMF Index , Dental Plaque/microbiology , Female , Humans , Male , Middle Aged , Mupirocin , Regression Analysis , Statistics, Nonparametric
15.
Caries Res ; 43(4): 308-13, 2009.
Article in English | MEDLINE | ID: mdl-19494490

ABSTRACT

The aim of this study was to enumerate and identify bifidobacteria from occlusal carious lesions in permanent and deciduous teeth. Samples of infected dentine were obtained from 24 active occlusal lesions in deciduous teeth and from 15 occlusal lesions in permanent teeth. Plaque samples from sound occlusal surfaces of 12 caries-free adults and 12 children were also obtained. The bifidobacterial strains were isolated in mupirocin-containing selective media, Gram-stained and subcultured for identification. Total bacterial counts were determined using fastidious anaerobic agar, and isolates were identified using genus-specific PCR primers and were confirmed by 16S rRNA sequencing. Bifidobacteria were isolated from 13 of the 15 occlusal lesions in the adults and formed 5.09 +/- 2.11% of the total cultivable flora. In the children, bifidobacteria were isolated from 16 of the 24 occlusal lesions and formed 7.4 +/- 2.6% of the total flora. No bifidobacteria were isolated from the occlusal surfaces of caries-free adults or children. A total of 424 bifidobacteria were identified and these were Bifidobacteriumdentium, Parascardovia denticolens, Scardoviainopicata, Bifidobacterium longum, Scardovia genomosp. C1 and Bifidobacterium breve. B. dentium was present in 14 out of the 16 bifidobacteria-positive samples from the lesions on the deciduous teeth and in 7 out of the 13 positive lesions in adults (p = 0.04). The present data suggest that bifidobacteria may play a role in the progression of occlusal caries lesions in both children and adults.


Subject(s)
Bifidobacterium/isolation & purification , Dental Caries/microbiology , Dental Enamel/microbiology , Dental Plaque/microbiology , RNA, Ribosomal, 16S/analysis , Adult , Bifidobacterium/classification , Bifidobacterium/genetics , Case-Control Studies , Child , Colony Count, Microbial , Dental Caries/pathology , Dental Enamel/pathology , Dentition, Permanent , Humans , RNA, Bacterial/analysis , Reference Values , Tooth, Deciduous/microbiology
16.
Vaccine ; 27(27): 3501-4, 2009 Jun 02.
Article in English | MEDLINE | ID: mdl-19464527

ABSTRACT

Vaccination against Plasmodium falciparum malaria could reduce the worldwide burden of this disease, and decrease its high mortality in children. Replication-defective recombinant adenovirus vectors carrying P. falciparum epitopes may be useful as part of a vaccine that raises cellular immunity to the pre-erythrocytic stage of malaria infection. However, existing immunity to the adenovirus vector results in antibody-mediated neutralization of the vaccine vector, and reduced vaccine immunogenicity. Our aim was to examine a population of children who are at risk from P. falciparum malaria for neutralizing immunity to replication-deficient recombinant chimpanzee adenovirus 63 vector (AdC63), compared to human adenovirus 5 vector (AdHu5). We measured 50% and 90% vector neutralization titers in 200 individual sera, taken from a cohort of children from Kenya, using a secreted alkaline phosphatase neutralization assay. We found that 23% of the children (aged 1-6 years) had high-titer neutralizing antibodies to AdHu5, and 4% had high-titer neutralizing antibodies to AdC63. Immunity to both vectors was age-dependent. Low-level neutralization of AdC63 was significantly less frequent than AdHu5 neutralization at the 90% neutralization level. We conclude that AdC63 may be a useful vector as part of a prime-boost malaria vaccine in children.


Subject(s)
Adenoviruses, Human/immunology , Adenoviruses, Simian/immunology , Antibodies, Viral/blood , Genetic Vectors/immunology , Malaria Vaccines/immunology , Pan troglodytes/virology , Vaccines, Synthetic/immunology , Animals , Child , Child, Preschool , Cohort Studies , Humans , Infant , Neutralization Tests , Seroepidemiologic Studies , Vaccination
17.
J Dent ; 37(7): 514-21, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19376633

ABSTRACT

AIMS: To determine the antimicrobial properties of a selection of dentine bonding agents [DBAs] using the disc diffusion and direct contact methods and an ex vivo method using extracted carious permanent molar teeth. METHODS: DBAs (n=15) were tested using Streptococcus mutans UA159 in disc diffusion and direct contact methods. In the ex vivo study 6 DBAs were selected and pre- and post-treatment samples of carious dentine (n< or =12) were taken. Samples were also taken post-acid-etching. The number of microorganisms in dentine sample was determined and compared. RESULTS: The inhibition zones and percent growth inhibition were related to the pH of the culture medium containing the DBA (p<0.01). Clearfill Protect Bond exhibited the greatest bacterial killing followed by ibond (99.8%+/-0.08 and 98.2+/-1.4, respectively). The phosphoric acid etchant alone resulted in an 83% killing. The in vitro tests results did not correlate. The ex vivo killing reflected the percent growth inhibition observed in the direct contact method. CONCLUSION: A guide to the potential antimicrobial activity of a DBA may be gained from an assessment of its pH when added to bacteriological culture medium. The direct contact method gives a better reflection of the killing of bacteria in infected dentine than the disk diffusion method. Killing in the ex vivo model gives a more realistic and more reliable method for determining the antibacterial activity of a given DBA and that comparisons of the relative inhibitory activity of DBAs should be tested using this ex vivo model.


Subject(s)
Anti-Infective Agents/pharmacology , Dentin-Bonding Agents/pharmacology , Streptococcus mutans/drug effects , Acid Etching, Dental , Bacteriological Techniques , Colony Count, Microbial , Culture Media , Dental Caries/microbiology , Dentin/microbiology , Humans , Hydrogen-Ion Concentration , Materials Testing , Methacrylates/pharmacology , Microbial Sensitivity Tests , Phosphoric Acids/pharmacology , Polymethacrylic Acids/pharmacology , Resin Cements/pharmacology
18.
Transpl Int ; 22(3): 313-22, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19054382

ABSTRACT

Although sirolimus (SRL) use in renal allograft recipients (RTX) is associated with improved renal function, proteinuria develops in a significant proportion. 48 SRL-treated RTX were evaluated for development of proteinuria and stratified by level of proteinuria after SRL therapy. The Proteinuria Group (n = 25, 52.1%) had new-onset proteinuria or >25% increase in proteinuria following SRL conversion; the Nonproteinuria Group had stable proteinuria <0.5 g/day throughout. There was a higher proportion of male RTX and female donors to male recipients in the Proteinuria Group, (24% vs. 10%, P = 0.008). Calcineurin inhibitor- and statin usage were significantly higher in the Nonproteinuria Group (8% vs. 17%, P = 0.046; 28% vs. 83%, P < 0.001 respectively) whereas biopsy-proven acute rejection was higher in the Proteinuria Group (68% vs. 33%, P = 0.037). SDS-PAGE analysis of urine from 23 RTX in the Proteinuria Group demonstrated glomerular proteinuria in 100% and tubular proteinuria in 87%. While male gender and gender mismatch may impact on glomerular proteinuria through inadequate nephron dose and subsequent hyperfiltration, concurrent cyclosporine use may mitigate the development of proteinuria in SRL-treated patients, through afferent arteriolar vasoconstriction. Glomerular injury occurring following acute rejection may further contribute to glomerular proteinuria. Statins, through their anti-inflammatory and anti-fibrotic effects, may protect against development of proteinuria.


Subject(s)
Graft Rejection/drug therapy , Immunosuppressive Agents/adverse effects , Kidney Transplantation , Proteinuria/chemically induced , Proteinuria/physiopathology , Sirolimus/adverse effects , Acute Disease , Adult , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Blood Pressure , Body Mass Index , Cyclosporine/administration & dosage , Diabetes Mellitus/epidemiology , Drug Therapy, Combination , Female , Graft Rejection/epidemiology , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Immunosuppressive Agents/administration & dosage , Lipids/blood , Male , Middle Aged , Nephrons/drug effects , Prevalence , Proteinuria/epidemiology , Sex Factors , Sirolimus/administration & dosage , Vasoconstriction/drug effects
19.
J Virol ; 82(8): 3822-33, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18256155

ABSTRACT

Human adenovirus serotype 5 (AdH5) vector vaccines elicit strong immune responses to the encoded antigen and have been used in various disease models. We designed AdH5 vectors expressing antigen under the control of a human cytomegalovirus (HCMV) immediate-early promoter containing its intron A sequence. The transcriptional levels of antigen and immune responses to antigen for vectors with the HCMV promoter with the intron A sequence (LP) were greater than those for AdH5 vectors using the HCMV promoter sequence without intron A (SP). We compared an E1E3-deleted AdH5 adenoviral vector, which affords more space for insertion of foreign sequences, and showed it to be as immunogenic as an E1-deleted AdH5 vector. Neutralizing antibodies to AdH5 limit the efficacy of vaccines based on the AdH5 serotype, and simian adenoviral vectors offer an attractive option to overcome this problem. We constructed E1E3-deleted human and simian adenoviral vectors encoding the pre-erythrocytic-stage malarial antigen Plasmodium berghei circumsporozoite protein. We compared the immunogenicity and efficacy of AdC6, a recombinant simian adenovirus serotype 6 vector, in a murine malaria model to those of AdH5 and the poxviral vectors MVA and FP9. AdC6 induced sterile protection from a single dose in 90% of mice, in contrast to AdH5 (25%) and poxviral vectors MVA and FP9 (0%). Adenoviral vectors maintained potent CD8(+) T-cell responses for a longer period after immunization than did poxviral vectors and mainly induced an effector memory phenotype of cells. Significantly, AdC6 was able to maintain protection in the presence of preexisting immunity to AdH5.


Subject(s)
Adenoviruses, Simian/genetics , Cytomegalovirus/genetics , Malaria Vaccines/immunology , Malaria/prevention & control , Plasmodium berghei/immunology , Protozoan Proteins/immunology , Adenoviruses, Human/genetics , Adenoviruses, Human/immunology , Animals , CD8-Positive T-Lymphocytes/immunology , Cell Line , Female , Genetic Vectors , Immunologic Memory , Mice , Mice, Inbred BALB C , Plasmodium berghei/genetics , Promoter Regions, Genetic , Protozoan Proteins/genetics , T-Lymphocyte Subsets/immunology , Time Factors
20.
Genomic Med ; 2(3-4): 83-91, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19319668

ABSTRACT

Background/aims Several studies have reported varying results of the influence of ACE gene on ACEI/ARB therapy. The efficacy of high dose ARB and its influence on ACE gene have not been explored. This is a 6 year randomised trial in IgA nephritis comparing high dose ARB (Losartan 200 mg/day) with normal dose ARB (Losartan 100 mg/day), normal dose ACEI (20 mg/day) and low dose ACEI (10 mg/day). Results Patients on high dose ARB had significantly lower proteinuria, 1.0 +/- 0.8 gm/day compared to 1.7 +/- 1.0 g/day in the other groups (P = 0.0005). The loss in eGFR was 0.7 ml min(-1)year(-1) for high dose ARB compared to 3.2-3.5 ml min(-1)year(-1) for the other three groups (P = 0.0005). There were more patients on high dose ARB with improvement in eGFR compared to other three groups (P < 0.001). Comparing patients with the three ACE genotypes DD, ID and II, all three groups responded well to therapy with decrease in proteinuria (P < 0.002). Only those on low dose ACEI (10 mg/day) with the I allele had increased in ESRF (P = 0.037). Conclusion High dose ARB is more efficacious in reducing proteinuria and preserving renal function when compared with normal dose ARB and ACEI, and also obviates the genomic influence of ACE gene polymorphism on renal survival.

SELECTION OF CITATIONS
SEARCH DETAIL
...